Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...

Microbial Source: The most widely used due to cost-effectiveness, scalability, and broad substrate specificity. Microbial lipases, derived from fungi and bacteria, dominate Vietnam’s market, ...

For those looking to find strong Basic Materials stocks, it is prudent to search for companies in the group that are outperforming their peers. Novozymes A/S (NVZMY) is a stock that can certainly grab ...

Here are three stocks with buy rank and strong income characteristics for investors to consider today, May 14th: Southwest Gas SWX: This regulated utility company that provides natural gas services, ...

Novonesis, a world-leading biosolutions company, co-hosted its 'Unlocking Value for a Sustainable Future' Partnering Day 2025 ...

Novozymes (NVZMY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

The global leader in biosolutions, Novonesis, had a strong start to its financial year with organic sales growth of 11% and an adjusted EBITDA margin of 38.3%. The company ...

Danish packaging firm Faerch has appointed Pernille Lind Olsen as its new chief executive officer, effective 1 July 2025.

Monsanto, the world’s largest seed company, said Tuesday a deal with Danish company Novozymes to form a long-term research and development alliance should accelerate the release of microbial-based ...

Novonesis formed in January 2024, a merger of Novozymes and Chr Hansen. The company offers a portfolio of biological solutions designed to help producers enhance productivity, yields and profitability ...

Biology and technology are accelerating the green transition. The merger of Novozymes and Chr. Hansen has created Novonesis, a global leader in what the new company calls “biosolutions.” ...

Danish enzyme firm Novozymes has completed its $25.6 million cash deal to buy a controlling stake in Saskatoon inoculant maker Philom Bios. The deal gives Philom Bios access to Novozymes’ resources ...